FDA Unveils Draft Social Media Guidance for Drug, Device Makers

In draft guidanceissued Tuesday, FDA outlined how drugmakers and medical device makers should highlight the benefits and risks of their products via social media and how they should address and correct misinformation regarding their products posted by third parties, the New York Times reports (Tavernise,  New York Times, 6/17). Continue reading